Terms ending in 2039
Every in-force patent on Sanofi's record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,478,737 | Conserving Power in an Injection Device In force · High confidence | Sanofi | In force | High confidence | |
| US 11,331,429 | Cartridge for Dosage Sensing In force · High confidence | Sanofi | In force | High confidence | |
| US 11,639,392 | ANTI-IL-1R3 Antibodies for Use in Inflammatory Conditions In force · High confidence | Sanofi Biotechnology SAS | In force | High confidence | |
| US 12,698,334 | ANTI-IL-1R3 Antibodies for Use in Inflammatory Conditions In force · High confidence | Sanofi Biotechnology | In force | High confidence | |
| US 11,834,689 | Incorporation of Unnatural Nucleotides and Methods Thereof In force · Medium confidence | Sanofi | In force | Medium confidence | |
| US 11,517,678 | Cartridge with Distributed Electronic Components In force · High confidence | Sanofi | In force | High confidence | |
| US 11,053,309 | Methods for Treating Active Eosinophilic Esophagitis In force · High confidence | Sanofi Biotechnology | In force | High confidence | |
| US 12,214,174 | Data Collection Device for Attachment to an Injection Device In force · Medium confidence | Sanofi | In force | Medium confidence | |
| US 12,337,154 | Acoustic Detection of a Usage of an Injection Device In force · Medium confidence | Sanofi | In force | Medium confidence | |
| US 12,458,759 | RFID Dose Tracking Mechanism for Injection Devices In force · Medium confidence | Sanofi | In force | Medium confidence | |
| 87 more term ends in 2039 · Pro | |||||
10 of 97 patents shown. Soonest term end first, then patent number.
Pro members see all 97.
92 of these are in force and held by Sanofi.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.